COSMOS HEALTH NEW DL-01 (V67A) - Total Assets
Based on the latest financial reports, COSMOS HEALTH NEW DL-01 (V67A) holds total assets worth €65.48 Million EUR (≈ $76.55 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of COSMOS HEALTH NEW DL-01 for net asset value and shareholders' equity analysis.
COSMOS HEALTH NEW DL-01 - Total Assets Trend (2021–2025)
This chart illustrates how COSMOS HEALTH NEW DL-01's total assets have evolved over time, based on quarterly financial data.
COSMOS HEALTH NEW DL-01 - Asset Composition Analysis
Current Asset Composition (December 2025)
COSMOS HEALTH NEW DL-01's total assets of €65.48 Million consist of 58.6% current assets and 41.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 1.1% |
| Accounts Receivable | €19.63 Million | 30.0% |
| Inventory | €5.78 Million | 8.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €7.52 Million | 11.5% |
| Goodwill | €49.70K | 0.1% |
Asset Composition Trend (2021–2025)
This chart illustrates how COSMOS HEALTH NEW DL-01's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see COSMOS HEALTH NEW DL-01 (V67A) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: COSMOS HEALTH NEW DL-01's current assets represent 58.6% of total assets in 2025, a decrease from 80.6% in 2021.
- Cash Position: Cash and equivalents constituted 1.1% of total assets in 2025, up from 0.6% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 30.0% of total assets.
COSMOS HEALTH NEW DL-01 Competitors by Total Assets
Key competitors of COSMOS HEALTH NEW DL-01 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jointown Pharmaceutical Group Co Ltd
SHG:600998
|
China | CN¥112.28 Billion |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
China | CN¥21.18 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$46.10 Million |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
COSMOS HEALTH NEW DL-01 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.00 | 0.99 | 1.44 |
| Quick Ratio | 0.85 | 0.82 | 1.24 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €116.41K | €-296.19K | €11.03 Million |
COSMOS HEALTH NEW DL-01 - Advanced Valuation Insights
This section examines the relationship between COSMOS HEALTH NEW DL-01's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.97 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 20.6% |
| Total Assets | €65.48 Million |
| Market Capitalization | $14.30 Million USD |
Valuation Analysis
Below Book Valuation: The market values COSMOS HEALTH NEW DL-01's assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: COSMOS HEALTH NEW DL-01's assets grew by 20.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for COSMOS HEALTH NEW DL-01 (2021–2025)
The table below shows the annual total assets of COSMOS HEALTH NEW DL-01 from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €65.48 Million ≈ $76.55 Million |
+20.56% |
| 2024-12-31 | €54.31 Million ≈ $63.50 Million |
-17.73% |
| 2023-12-31 | €66.01 Million ≈ $77.18 Million |
-2.97% |
| 2022-12-31 | €68.04 Million ≈ $79.54 Million |
+37.65% |
| 2021-12-31 | €49.43 Million ≈ $57.79 Million |
-- |
About COSMOS HEALTH NEW DL-01
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It als… Read more